Medipass expands its service offering for hospitals and healthcare systems with the acquisition of IML – International Medical for Life, an Italian company specialised in mobile diagnostics. IML provides mobile CT, MRI, mammography, haemodynamics, and PET units, supporting public and private hospitals with flexible and accessible solutions.
Through the acquisition of IML and the incorporation of mobile diagnostics, Medipass can efficiently ensure operational continuity in imaging departments during renovations or technological upgrades of fixed equipment. Mobile units can also be deployed to expand access in underserved areas and support departments facing long waiting times.
IML’s solutions stand out for their flexibility and accessibility: seamless integration with hospital RIS/PACS systems, options for both local and remote reporting, 24-hour operation, and full accessibility for stretcher and disabled patients.
Joining Ergéa is an extraordinary opportunity for growth and development in the mobile diagnostic imaging sector, with important mutual synergies. Being part of an international group will also allow us to expand our fleet of mobile units and respond even more effectively to the growing needs of both Italian and international markets.
Silvio Plazzotta and Fabrizio Fregona, Co-CEOs of IML
Our entry into the rapidly growing mobile diagnostics sector brings us even closer to patients and customers, with a more flexible portfolio of services that guarantees accessibility, proximity, and continuity of care.
Michele Corti, CEO of Medipass
